CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-21 | Kauffman Michael Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-06-21 | Rowinsky Eric K Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-06-21 | BARBERICH TIMOTHY J Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-03-15 | BARBERICH TIMOTHY J Director | Purchase | +33,000 | $3.21 | $106K | 168,000 |
| 2019-01-03 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-01-03 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-01-03 | Paterson Dan Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-01-03 | Paterson Dan Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-01-03 | Lobacki Joseph M Executive VP & CCO | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2019-01-03 | Lobacki Joseph M Executive VP & CCO | Grant or award · Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2019-01-03 | Gagnon Robert E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-01-03 | Gagnon Robert E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-01-03 | Forrester Robert President and CEO | Grant or award · Stock Option (Right to Buy) | +240,000 | 240,000 | ||
| 2019-01-03 | Forrester Robert President and CEO | Grant or award · Stock Option (Right to Buy) | +240,000 | 240,000 | ||
| 2018-10-17 | Consylman Gina Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-09-28 | BARBERICH TIMOTHY J Director | Purchase | +5,000 | $7.31 | $37K | 135,000 |
| 2018-09-28 | Lobacki Joseph M Executive VP & CCO | Purchase | +3,000 | $7.30 | $22K | 10,700 |
| 2018-09-28 | Paterson Dan Chief Operating Officer | Purchase | +3,000 | $7.00 | $21K | 23,286 |
| 2018-09-28 | Forrester Robert President and CEO | Purchase | +2,000 | $7.00 | $14K | 221,234 |
| 2018-09-28 | Kauffman Michael Director | Purchase | +4,000 | $7.49 | $30K | 4,000 |
Page 19 of 23 · 448 trades